What You Should Know:
– Today, Oracle announced that all required antitrust approvals have been obtained for its proposed $28.3B ($95 per share) acquisition of Cerner, including European Commission clearance.
– Oracle expects to complete the tender offer promptly following the expiration of that offer at midnight Eastern time on June 6, 2022. Completion of the tender offer remains subject to the conditions described in the tender offer statement on Schedule TO filed by Oracle with the U.S. Securities and Exchange Commission on January 19, 2022, as amended.
– Oracle Chairman and Chief Technology Officer Larry Ellison will discuss the Cerner acquisition and Oracle’s new suite of cloud-based health management applications at an online event on June 9, 2022, at 3:00 p.m. CT. Register for the event.